Extended safety check for lifelong hormone disorder treatment

NCT ID NCT05299554

Completed Disease control Sponsor: Neurocrine UK Limited Source: ClinicalTrials.gov ↗

Summary

This study followed 76 adults with congenital adrenal hyperplasia (CAH) to check the long-term safety of a medication called Chronocort. Participants either continued taking Chronocort or switched to it from their standard therapy. The main goal was to monitor for side effects and see how well the body tolerated the treatment over an extended period.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

National Institutes of Health Center

Bethesda, Maryland, 20892-1932, United States
Neurocrine Investigational Site in Asahi-ku

Yokohama, Kanagawa, 241-0811, Japan
Neurocrine Investigational Site in Caen

Caen, 14033, France
Neurocrine Investigational Site in California

Los Angeles, California, 90027, United States
Neurocrine Investigational Site in California

Orange, California, 92868, United States
Neurocrine Investigational Site in Florida

Jacksonville, Florida, 32207, United States
Neurocrine Investigational Site in Iowa

Iowa City, Iowa, 52242, United States
Neurocrine Investigational Site in Michigan

Ann Arbor, Michigan, 48114, United States
Neurocrine Investigational Site in Minnesota

Rochester, Minnesota, 55901, United States
Neurocrine Investigational Site in Nevada

Las Vegas, Nevada, 89148, United States
Neurocrine Investigational Site in Okura

Setagaya-Ku, Tokyo, 157-8535, Japan
Neurocrine Investigational Site in Paris

Paris, 75651, France
Neurocrine Investigational Site in Pessac

Pessac, 33604, France
Neurocrine Investigational Site in Texas

Dallas, Texas, 75235, United States
Neurocrine Investigational Site in Toulouse

Toulouse, 31059, France
Neurocrine Investigational Site in Toulouse (Children's hospital)

Toulouse, 31059, France
Neurocrine Investigational Site in Toyama

Shinjuku-Ku, Tokyo, 162-8655, Japan
Neurocrine Investigational Site in Washington

Seattle, Washington, 98105, United States
Neurocrine Investigational Site in Wisconsin

Milwaukee, Wisconsin, 53226, United States
Neurocrine Investigational Site in Yushima

Bunkyō-Ku, Tokyo, 113-8519, Japan
Neurocrine investigational Site in Lyon

Lyon, 69677, France

Conditions

Explore the condition pages connected to this study.

CONGENITAL ADRENAL HYPERPLASIA